Pinteon Therapeutics
Newton
About Pinteon Therapeutics
Pinteon Therapeutics focuses on the discovery and development of breakthrough therapeutics targeting Pin1. Pin1 acts as a central regulator in cancer development and growth as well as a number of other disease areas including CNS and autoimmune diseases. By inhibiting or activating Pin1, Pinteon will normalize aberrant disease processes and improve patient outcomes in these high unmet medical need indications. Pinteon Therapeutics was founded in 2014 and is headquartered in Newton, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $52.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2022)
- Website: pinteon.com
- Phone: 917-607-0015
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pinteon-therapeutics-85279 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.